MIRA
INFORM REPORT
|
Report Date : |
17.10.2007 |
IDENTIFICATION DETAILS
|
Name : |
EL NASR CO FOR
PHARMACEUTICAL CHEMICALS |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
1960 |
|
|
|
|
Com. Reg. No.: |
114118 |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Engaged
in the manufacture and the export of pharmaceutical chemicals, veterinary and
pharmaceutical preparations, antibiotics, medical and special solutions. |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
US$ 850,000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
SUMMARY
Company Name : EL NASR CO FOR PHARMACEUTICAL CHEMICALS
Country of Origin :
Legal Form : Egyptian Joint Stock Company
Registration Date : 1960
Commercial Registration Number : 114118
Issued Capital : £E 50,000,000
Paid up Capital : £E 50,000,000
Total Workforce : 2,800
Line of Business :
Manufacture and the export of pharmaceutical
chemicals, veterinary
and pharmaceutical preparations, antibiotics,
medical and special
solutions.
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
COMPANY NAME
EL NASR CO FOR
PHARMACEUTICAL CHEMICALS
ADDRESS
Registered & Physical Address
Street :
Area :
PO Box : 7
Town :
Country :
Telephone : (20-2) 5746168
Facsimile : (20-2) 5771381
Premises
Subject operates
from a large suite of offices that are rented and located in the Central
Business Area of Cairo.
Branch Office (s)
Location Description
·
Abu Zaabal Owned
factory premises
Kaliubeya
Tel: (20-2)
44698450 / 44620899
Fax: (20-2)
44698977
·
Bakous
Station
Tel: (20-3)
4862872
Fax: (20-3)
4862872
·
El Selselah Tower Rented
sales office
Azareta
Tel: (20-3)
5708578
Fax: (20-3)
5708578
KEY PRINCIPALS
·
Dr. Saber Hassanein Mohamed Chairman
·
Abd El Hamid Mahsoub Finance
Manager
·
Dr. Mohamed Hamed Shedeed Marketing
Manager
·
Dr. Samy Hafez Export
Manager
·
Mohamed Galal Administration
Manager
·
Ahmed El Gebal IT
Manager
LEGAL FORM &
OWNERS
Date of Establishment : 1960
Legal Form :
Societe Anonyme Egyptienne
– SAE (Egyptian Joint Stock Company)
Commercial Reg. No. : 114118
Issued Capital : £E 50,000,000
Paid up Capital : £E 50,000,000
Name of Shareholder
(s) Percentage
·
Holding Co for Pharmaceuticals, Chemicals & Medical Appliances
100%
Tel: (20-2) 25910439
Fax:
(20-2) 25916866
Note to the Legal Form
The Egyptian Company Law provides that the capital of a Societe
Anonyme Egyptienne - SAE – should not be less than £E 500,000 if shares are
offered to the public and £E 250,000 if not. If shares are offered to the
public they are freely transferable, if not, transfer may be restricted.
Liability of shareholders is limited.
LINE OF BUSINESS
Operations : Engaged in the
manufacture and the export of pharmaceutical chemicals, veterinary and
pharmaceutical preparations, antibiotics, medical and special solutions.
Import Countries
:
Export Countries
:
Brand Names : ADWIC and VITWIGK
Subject has a
workforce of approximately 2,800 employees.
FINANCIAL
HIGHLIGHTS
Companies
registered in
BANKERS
·
Banque
du Caire SAE
Tel: (20-2)
5763492
Fax: (20-2)
5787286
·
National
Bank of
24,
Tel : (20-2) 3924175
Fax : (20-2) 3924143
·
Commerz
Bank
Tel: (49-228) 605111
PAYMENT HISTORY
No complaints
regarding subject’s payments have been reported.
GENERAL COMMENTS
Opinion on the
credit figure of US$ 100,000:
During the course of
this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk and the above credit figure is
within subject’s financial means.
Maximum suggested
credit figure: US$ 850,000
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)